Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03673956 · ClinicalTrials.gov registry record · Phase 1
Topical Antibiotics in Chronic Rhinosinusitis
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
NCT03673956: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT03673956 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03673956, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
Researchers are trying to find out if patients develop antibiotic resistant organisms after the use of topical antibiotics in the treatment of chronic rhinosinusitis.
Interventions
- DRUG Vancomycin
- DRUG Mupirocin
- DRUG Levofloxacin
- DRUG Tobramycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-09-26 |
| Est. Completion | 2021-02-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03673956
The ClinicalTrials.gov registry entry for NCT03673956 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Vancomycin is the first listed.
NCT03673956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03673956 about?
NCT03673956 is a clinical study titled "Topical Antibiotics in Chronic Rhinosinusitis". Researchers are trying to find out if patients develop antibiotic resistant organisms after the use of topical antibiotics in the treatment of chronic rhinosinusitis.
What is the current status of trial NCT03673956?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2018-09-26. Estimated completion is 2021-02-01.
What interventions are being tested in trial NCT03673956?
The interventions under investigation include: Vancomycin (DRUG), Mupirocin (DRUG), Levofloxacin (DRUG), Tobramycin (DRUG).
Who is sponsoring clinical trial NCT03673956?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.